The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Adenosine 3 mg/ml solution for injection in pre-filled syringe

3 milligram(s)/millilitre Solution for injection

Fresenius Kabi Deutschland GmbHPA2059/004/001

Main Information

Trade NameAdenosine 3 mg/ml solution for injection in pre-filled syringe
Active SubstancesADENOSINE
Strength3 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/004/001

Group Information

ATC CodeC01EB Other cardiac preparations
C01EB10 adenosine

Status

Authorised/WithdrawnAuthorised
Licence Issued28/08/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back